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Leucine side chain dynamicsLung surfactant protein B (SP-B) is a lipophilic protein critical to lung function at ambient pressure. KL4 is a
21-residue peptide which has successfully replaced SP-B in clinical trials of synthetic lung surfactants. CD
and FTIR measurements indicate KL4 is helical in a lipid bilayer environment, but its exact secondary
structure and orientation within the bilayer remain controversial. To investigate the partitioning and
dynamics of KL4 in phospholipid bilayers, we introduced CD3-enriched leucines at four positions along the
peptide to serve as probes of side chain dynamics via 2H solid-state NMR. The chosen labels allow distinction
between models of helical secondary structure as well as between a transmembrane orientation or
partitioning in the plane of the lipid leaﬂets. Leucine side chains are also sensitive to helix packing
interactions in peptides that oligomerize. The partitioning and orientation of KL4 in DPPC/POPG and POPC/
POPG phospholipid bilayers, as inferred from the leucine side chain dynamics, is consistent with monomeric
KL4 lying in the plane of the bilayers and adopting an unusual helical structure which confers amphipathicity
and allows partitioning into the lipid hydrophobic interior. At physiologic temperatures, the partitioning
depth and dynamics of the peptide are dependent on the degree of saturation present in the lipids. The
deeper partitioning of KL4 relative to antimicrobial amphipathic α-helices leads to negative membrane
curvature strain as evidenced by the formation of hexagonal phase structures in a POPE/POPG phospholipid
mixture on addition of KL4. The unusual secondary structure of KL4 and its ability to differentially partition
into lipid lamellae containing varying levels of saturation suggest a mechanism for its role in restoring lung
compliance.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Lung surfactant is a highly organized, lipid-rich ﬂuid which lines
the highly curved alveoli and lowers surface tension. Lung surfactant
protein B (SP-B) is an extremely hydrophobic protein which is critical
to the proper trafﬁcking of lipids in lung surfactant and establishment
of a stable air–water interface [1,2]. Mature SP-B is a homodimer
with two 79–81 amino acid disulﬁde-linked subunits containing high
levels of valine, leucine, isoleucine, proline, alanine, phenylalanine,spiratory distress syndrome;
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ll rights reserved.and tryptophan [3–5]. Each monomer contains an additional six
cysteines that form intramolecular disulﬁde bonds and their pattern
of disulﬁde formation along with lipophilicity place SP-B in the
saposin family of proteins. The hydrophobicity and disulﬁde bridges
in SP-B also make puriﬁcation or heterologous expression of the
protein in large quantities impractical. Synthetic, peptide-based lung
surfactant replacements for treatment of RDS have shown promise
and would remove the immunologic risks associated with current
therapies utilizing animal-derived lung surfactant [6–8].
Much of the activity of SP-B in altering lipid organization and
dynamics can be recapitulated by the N- and C-terminal 20-25 amino
acid fragments of SP-B [4,9]. Both peptides form helices in lipid
environments [10–13], but their individual roles in lipid trafﬁcking are
not well understood. While both peptides have considerable surface
activity, activity similar to native SP-B has only been achieved with a
chimeric construct of the two peptides [14]. The C-terminus contains
many leucines and lacks aromatic residues while the N-terminus
contains four prolines aswell as a phenylalanine and a tryptophan. The
peptides also have different spacings of hydrophilic and hydrophobic
amino acids. These differences could lead to subtle variations in
secondary structure and partitioning into lipid lamellae as well as
different effects on phospholipid dynamics.
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KL4 peptide, KLLLLKLLLLKLLLLKLLLLK [8], which to date has shown the
greatest clinical success for treatment of respiratory distress syn-
drome (RDS) with synthetic surfactant [15–19]. The basis for the
primary sequence of KL4 was the charge distribution and hydrophilic/
hydrophobic ratio within SP-B59–80. However, their primary
sequences have only modest similarity. KL4 has also been found via
CD and FTIR to adopt a helical conformation in a lipid environment
[20–22], but the periodicity of the charged lysine residues is at odds
with the peptide adopting a canonical α-helical conformation (3.6
residues/turn) which is either amphipathic, for partitioning at the
lipid interface, or which can span the lipid bilayer in a TM orientation
without burying lysine side chains in the hydrophobic interior of the
bilayer. An early FTIR study of KL4 in DPPC/DPPG concluded the
peptide formed a helix spanning the bilayers and posited that KL4
mightmore closelymimic lung surfactant protein C (SP-C) rather than
the C-terminus of SP-B [20]. More recent IR studies of KL4 conclude
that it binds to the lipid interface but its structure and penetration are
lipid and pressure dependent [23]. An assay of the ability of KL4 to
cross ER microsomal membranes via translocon-mediated translation
in an in vitro transcription–translation system demonstrated that
when KL4 is expressed within a membrane protein host it can span
phospholipid bilayers [24]. While all of these experiments are well
suited for analyzing peptides which clearly form amphipathic or TM
α-helices, they are inherently low in resolution and are also sensitive
to sample conditions (hydration and P/L ratio in the case of FTIR and
ﬂanking protein sequences and integrity of the microsomal mem-
branes in the case of the in vitro translation assay). Additionally, many
of the published studies have been carried out at room temperature,
well below the melting temperature of DPPC (the primary lipid in
lung surfactant) or even lung surfactant itself, and with P/L ratios that
are much higher than is clinically relevant, raising the possibility of
peptide aggregation.
We have been utilizing solid-state NMR spectroscopy to gain a
higher-resolution understanding of the structure of KL4 and its
effects on lipid organization under physiologically relevant condi-
tions. In particular, the structure of KL4 in 4:1 DPPC/POPG and 3:1
POPC/POPG lipid mixtures and its effects on phospholipid dynamics
have been characterized. The former lipid composition is similar to
formulations commonly used in synthetic lung surfactant, while the
latter is a paradigm lipid system commonly employed to probe
peptide/lipid interactions, particularly in studies of cationic, amphi-
pathic helices [25–27]. Lipid phases of either of these compositionsFig. 1. Helical wheel plots of KL4 with varying (ϕ, ψ) torsion angles. (A) Wheel generated as
determined in POPC/POPG vesicles (ϕ, ψ=−105°,−30°); and (C) using the average torsion
hydrophobic moments resulting from the distribution of charged lysine side chains on the h
N-terminus is less structured relative to the rest of the helix.could also be found in localized areas of the alveoli during the
breathing cycle [28].
With 2H and 31P solid-state NMR we have established that the
lipids remain in lamellar phases up to 5 mol% KL4 with no evidence of
phase separation at physiologic (37 °C) temperature. The effects of
KL4 on the two lipids systems vary with the fatty acyl chains in the
DPPC/POPG mixture becoming more ordered on addition of peptide
while the hydrophobic interior of the POPC/POPG bilayers becomes
more disordered. Based on order parameter analyses, we interpreted
these observations as the peptide partitions more deeply into the
DPPC/POPG bilayers [29].
High-resolution measurements on KL4 in POPC/POPG bilayers via
magic angle spinning dipolar recoupling experiments indicate that
the peptide adopts an amphipathic helical structure due to the
backbone torsion angles diverging from canonical values (e.g., −65,
−45) in the lipid environment to form a helix with a lower angle of
rotation per residue and (φ, ψ) torsion angles that average (−105°,
−30°) [22]. More recentmeasurements on KL4 in DPPC/POPG suggest
that the peptide can form a helix which has an even lower angle of
rotation, increasing its amphipathicity, and allowing it to more deeply
partition into the lipid interior without adopting a TM orientation
(Fig. 1C; A.K. Mehta and J.R. Long, submitted for publication).
However, these measurements rely on determining the relative
orientations of 13C′ chemical shift anisotropy tensors, which have
degeneracies in particular regions of (φ, ψ) space, making it difﬁcult
to distinguish between a canonical α-helix (−63°,−45°) and a more
amphipathic helix (−63°, −81°). Molecular dynamics simulations,
coupled with ssNMR measurements of inter-residue 13C′→15N
distances and CD spectra, indicate that the (−63°, −81°) conforma-
tion is correct, but more conclusive data are needed. Additionally, the
orientation of the KL4 helix relative to the bilayer normal in DPPC/
POPG lipids cannot be conclusively determined from the lipid
dynamics measurements. Moreover, structural characterization via
dipolar recoupling experiments requires the removal of dynamics, via
ﬂash-freezing and lyophilization, removing any information on the
dynamics of the peptide which might be important to its function.
Based on the helical models for KL4 in DPPC/POPG and POPC/POPG
(Fig. 1), we chose to examine the side chain dynamics of four
leucines in KL4 as a function of temperature and lipid composition.
The four positions were selected to be sensitive to both helix pitch
and the orientation of KL4 within the lipid bilayers as well as to
provide insight into how the dynamics of the peptide might play a
role in its function. Leucine residue dynamics are also sensitive tosuming a canonical α-helix (ϕ, ψ=−63°,−42°); (B) using the average torsion angles
angles observed in DPPC/POPG vesicles (ϕ, ψ=−63°,−81°). Arrows indicate the net
elix surface. The ﬁrst lysine is not shown in (B) and (C) as NMR data indicate that the
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KL4 is monomeric under physiologically relevant conditions. This is
particularly of interest given the propensity of leucine residues to
enhance peptide oligomerization in membranes [31,32]. Variations
in temperature allow us to monitor the partitioning of KL4 in both
ﬂuid- and gel-phase lipid bilayers to infer how its structure,
orientation, and organization might vary between the different
sample conditions used in previous studies.
A particular advantage of probing peptide dynamics via 2H NMR is
that it enables us to study KL4 under close to physiologic conditions,
with full hydration of the lipids, and over a range of temperatures
relevant to the phase properties of the lipids. This allows us to assay
whether structural measurements, carried out on samples in which
dynamics are removed by ﬂash-freezing samples and subsequent
lyophilization, are consistent with the structure and dynamics of the
peptide under more physiologically relevant conditions. It also allows
us to monitor the interplay between peptide partitioning, lipid
dynamics, peptide secondary structure and dynamics, lipid poly-
morphisms, and temperature, providing important insights into lung
surfactant function and more generally the enthalpic and entropic
contributions underlying amphipathic peptides interactions with and
inﬂuence on phospholipid assemblies.
2. Materials and methods
2.1. Synthesis of KL4
Selectively deuterated 5-d3-L-leucine was purchased (Cambridge
Isotopes, Andover, MA) and fmoc-protected using standard protocols
[33]. Four variants of KL4, each containing a single enriched leucine (at
Leu3, Leu10, Leu12, or Leu19), were synthesized via solid-phase
peptide synthesis on a Wang resin (ABI 430, ICBR, UF), cleaved from
the resin with 90% TFA/5% triisopropyl-silane/5% water and ether
precipitated. The cleaved product was puriﬁed via RP-HPLC using a
C18 Vydac column with a water/acetonitrile gradient (containing
0.3% TFA). The fractions corresponding to KL4 were collected, and the
purity of the product was veriﬁed by mass spectrometry with a single
species of MW=2572. Dried peptide was weighed and dissolved in
methanol to a stock concentration of approximately 1 mM, and
aliquots were analyzed by amino acid analysis for a more accurate
determination of concentration and to verify purity (Molecular
Structure Facility, UC Davis).
2.2. Preparation of peptide: lipid samples
POPC, DPPC, and POPG were purchased as chloroform solutions
(Avanti Polar Lipids, Alabaster, AL) and concentrations were veriﬁed
by phosphate analysis [34] (Bioassay Systems, Hayward, CA). The
lipids were mixed at a molar ratio of 4:1 DPPC/POPG and 3:1 POPC/
POPG in chloroform and aliquoted. For samples containing peptide,
a methanol solution of KL4 was added to lipid solutions with
ﬁnal protein/lipid (P/L) molar ratio of 1:50 to match the clinical
formulation of KL4. The sampleswere dried under a stream of nitrogen
with the sample temperature maintained at 42–50°C in a water bath;
the resulting ﬁlms were suspended in warm cyclohexane, ﬂash-
frozen, and lyophilized overnight to remove residual solvent.
2.3. Solid-state NMR analysis
For each solid-state NMR sample, 20–30 mg of peptide–lipid
powder was placed in a 5mmdiameter NMR tube and 200 μL of buffer
containing 5 mM HEPES at pH 7.4, 140 mM NaCl, and 1 mM EDTA in
2H depleted water (Cambridge Isotopes, Andover, MA) was added.
NMR samples were then subjected to 3–5 freeze–thaw cycles with
gentle manual agitation to form MLVs. 2H NMR data were collected
on a 500 MHz Bruker Avance system (Billerica, MA) using a standardhigh resolution 5 mm broadband probe and a quad-echo sequence
(90°–τ–90°–τ–acq with τ=30 μs) with a B1 ﬁeld of 40 kHz. Spectra
were acquired with 100,000–400,000 transients, a 0.2-second recycle
delay time, and 500 kHz sweepwidth. Prior to Fourier transformation,
spectra were phased, symmetrized by adding the complex conjugate,
and damped with 200 Hz exponential line broadening (or 500 Hz for
low signal spectra at the lowest temperature), with removal of signal
between±200 Hz (±500 Hz) ascribed to residual 2H2O. Spectra were
acquired over a temperature range of −10 to 40 °C. Unsymmetrized
spectra without solvent removal are available in the Supplementary
Data. 31P NMR data were collected on a 600 MHz Bruker Avance
system (Billerica, MA) using a standard 5 mm BBO probe. Proton
decoupling (25 kHz) was employed during acquisition to remove
dipolar couplings. Spectra were acquired with 512–1024 scans and a
5-second recycle delay between scans to minimize RF sample heating.
Chemical shift referencing is relative to an external phosphate buffer
standard.
3. Results
3.1. Leucine side chain dynamics for KL4 in POPC/POPG lipid vesicles
2H solid-state NMR spectra for Leu3, Leu10, Leu12, and Leu19 in
3:1 POPC/POPG as a function of temperature and label position are
shown in Figs. 2 and 3. First moment analyses of the spectra are
provided in the Supplementary Data. The gel→liquid crystalline
phase transition temperature of this lipid mixture is −3 °C. At
temperatures near the phase transition temperature, the Leu3 and
Leu12 positions exhibit less dynamics relative to the Leu10 and Leu19
positions. The breadth and shape of the Leu3 and Leu12 powder
patterns at−10 °C are consistent with the deuterated leucine methyl
groups solely undergoing 3-fold rotation about the Cγ\Cδ bond; the
Leu10 and Leu12 line shapes are consistent with additional motion
about the Cβ\Cγ and/or Cα\Cβ bonds [30,35,36]. At 0 °C, the Leu3
and Leu12 positions begin to exhibit dynamics about the Cβ\Cγ or
Cα\Cβ bonds, but they are more limited relative to the Leu10 and
Leu19 positions. In contrast, at 14 °C, the line shapes for Leu3, Leu12,
and Leu19 have signiﬁcantly narrowed relative to the Leu10 position.
The dissimilarity in dynamics of the Leu10 and Leu12 residues as well
as the differences between Leu3 and Leu19 clearly rule out a TM
orientation in the POPC/POPG lipid bilayers at all the monitored
temperatures. Due to the phase transition temperature of the lipids
being similar to the freezing point of water, with signiﬁcant dynamics
remaining only in the hydrophobic interior of the lipid bilayers at
−10 °C, we interpret the contrast in dynamics between Leu3 and
Leu10 relative to Leu12 and Leu19 as a function of temperature as the
Leu3 and Leu10 positions partitioning closer to the lipid/water
interface while the Leu12 and Leu19 positions partition more deeply
into the hydrophobic interior of the lipid bilayers. The correlation of
dynamics between the Leu10 and Leu19 positions as well as between
the Leu12 and Leu3 positions is also more consistent with the helical
model shown in Fig. 1C rather than a canonical α-helix (Fig. 1A),
which would predict correlations between Leu3 and Leu10 and
between Leu12 and Leu19 if the helix axis lie in the plane of the
lipid leaﬂet.
At higher temperatures (14 and 25 °C), the Leu3, Leu12, and Leu19
spectra exhibit line shapes consistent with more motion about the
Cβ\Cγ and/or Cα\Cβ bonds, while the Leu10 position still exhibits
limited dynamics. This is consistent with the Leu10 position
partitioning more deeply into the lipid interior while the Leu3,
Leu12, and Leu19 residues partition at the lipid interface and is
predicted by the helical structure observed for KL4 at ambient
temperatures in POPC/POPG vesicles (Fig. 1B). At 40 °C, a small
decrease in dynamics is observed for the Leu19 position while the
Leu3 and Leu12 positions continue to show more motion. This is
consistent with the peptide partitioning slightly deeper into the lipid
Fig. 2. Deuterium NMR spectra as a function of temperature for the various 5-d3-L-leucine enriched position in KL4 in samples containing POPC/POPG vesicles.
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KL4, resulting in a small change in helix pitch and subsequent increase
in hydrophobic moment, as in the model shown in Fig. 1C.
3.2. Leucine side chain dynamics for KL4 in DPPC/POPG lipid vesicles
2H solid-state NMR spectra for Leu3, Leu10, Leu12, and Leu19 in
4:1 DPPC/POPG as a function of temperature and label position are
shown in Fig. 4; ﬁrst moment analyses are provided in the
Supplementary Data. The gel→liquid crystalline phase transition
of this lipid mixture is at 36 °C [29]. Below the phase transition
temperature (e.g., 25 °C), all four positions exhibit decreased
dynamics consistent with the methyl groups undergoing 3-fold
rotation about the Cγ\Cδ bond and limited motion about the Cβ\Cγ
and/or Cα\Cβ bonds. The dynamics of the Leu12 position is slightly
less restricted than that of the Leu19 position, for which the spectrum
has a lower ﬁrst moment than the Leu3 and Leu10 positions,
consistent with differences in partitioning. The dynamics of all four
positions is similar to that seen in 3:1 POPC/POPG lipids at lower
temperatures, as would be expected given the differences in the phase
transition temperatures of the lipids.Fig. 3. Deuterium NMR spectra as a function of label position for the various 5-d3-Above the phase transition (40 °C), the Leu3 and Leu12 side chains
are much more dynamic while the Leu10 and Leu19 positions
continue to exhibit only limited dynamics. The dissimilarity in
dynamics of the Leu10 and Leu12 residues as well as the differences
between Leu3 and Leu19 also clearly rule out a TM orientation in
DPPC/POPG lipids. The change in the relative dynamics of the four
positions with the phase of the phospholipids suggests changes in the
partitioning and/or secondary structure of KL4 with temperature
and underscores the need to study KL4 at physiologically relevant
temperatures, particularly in DPPC-rich mixtures given its high
transition temperature. The reduced dynamics at the Leu10 and
Leu19 positions suggests that they are partitioned into the hydro-
phobic interior of the lipid bilayers. The correlation of dynamics
between the Leu10 and Leu19 positions as well as between the Leu12
and Leu3 positions is again more consistent with the helical models
shown in Fig. 1C rather than a canonical α-helix (Fig. 1A) or the helix
modeled in Fig. 1B. The dynamics at 40 °C for all four positions in
DPPC/POPG is attenuated relative to in POPC/POPG, consistent with
the peptide partitioning more deeply into the DPPC/POPG hydropho-
bic interior as was previously inferred by examining the dynamics of
the fatty acyl chains [29].L-leucine enriched position in KL4 in samples containing POPC/POPG vesicles.
Fig. 4. Deuterium NMR spectra as a function of label position for the various 5-d3-L-
leucine enriched position in KL4 in samples containing DPPC/POPG vesicles.
Fig. 5. Phosphorous NMR spectra as a function of temperature for 3:1 POPE/POPG lipid
vesicles with and without 3 mol% KL4.
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curvature strain
31P solid-state NMR spectra of 3:1 POPE/POPG MLVs with and
without 3 mol% KL4 are shown as a function of temperature in Fig. 5.
At lower temperatures, the spectra are indicative of lamellar lipid
structures. The average head group orientations of the PE and PG
lipids relative to the membrane normal are similar, leading to a
single lamellar line shape for the mixture. For the sample containing
only phospholipids, the MLVs align signiﬁcantly in the strong
magnetic ﬁeld leading to a very strong signal at the perpendicular
edge of the line shape and almost no signal at the parallel edge.
Addition of KL4 leads to less lipid alignment and a more typical
lamellar line shape. The alignment of phospholipid vesicles at the
ﬁeld strengths utilized and the disruption of this alignment by KL4
have been previously documented [29]. At higher temperatures,
the phospholipids undergo a transition to an isotropic phase, as
evidenced by the appearance of a resonance near 0 ppm at 55 °C for
the sample containing only phospholipids. This transition is complete
by 61 °C and further changes in the line shape are not observed.
However, for the POPE/POPG sample containing KL4, the transition
from a lamellar phase does not occur until above 61 °C, and the
appearance of two separate spectral features is observed at 67 °C.
The peak near 0 ppm is consistent with an isotropic phase, while the
feature observed at −4 ppm is suggestive of an inverted hexagonal
phase. Heating further to 80 °C conﬁrms the formation of hexagonal
phase structures with a clear spectral line shape that is reversed
relative to the lamellar line shape and half its width. A signiﬁcant
fraction of the phospholipids remain in the isotropic phase, which
can be expected given the high percentage of POPG in the sample
and the relatively low concentration of KL4 relative to the
phospholipids. The induction of hexagonal phase structures in
POPE/POPG mixtures by KL4 demonstrates that the peptide induces
negative membrane curvature strain.
4. Discussion
Models for KL4 secondary structure and partitioning into lipid
bilayers are presented in Fig. 6 [37]. Four possibilities are shown: an
α-helix lying in the plane of the bilayers; an α-helix spanning the
bilayer; an alternative helical structure, based on our NMR measure-
ments of KL4 in DPPC/POPG, lying in the plane of the bilayers; and the
alternative helical structure spanning the bilayer. The 21-residuelength of the KL4 peptide is sufﬁcient for it to span the lipid bilayers in
a TM orientation, but it would require the burying of 2–3 lysine side
chains into the hydrophobic interior. While lysines have a lower
energetic barrier for partitioning into lipid bilayers than other basic
residues, a TM orientation is only possible if the hydrophobic
interaction of the leucine side chains and the overall secondary
structure overcome this barrier. Previous studies of peptides contain-
ing similar percentages of leucines and lysines indicate that a stable
TM orientation can only be achieved when the lysines are distributed
closer to the N- and C-termini [38]. Nonetheless, a recent in vitro
transcription–translation assay found KL4 is able to cross the
membrane [24]. However, this assay relies on the integration of KL4
into the Escherichia coli inner membrane protein leader peptidase
(Lep), which is translated in ER-derived microsomal membranes and
the resulting protein is assayed for glycosylation after proteinase K
digestion. The assay is problematic in two regards. First, the ﬂanking
sequences of the Lep protein may inﬂuence the secondary structure of
the integrated peptide. Second, KL4 is known to inﬂuence lipid
dynamics and trafﬁcking and thus may affect the integrity of the
microsomal membranes. Assuming an α-helical conformation, KL4
possesses a low hydrophobic moment and the predicted ΔGapp for the
KL4 sequence inserting into ER membranes is −2.14 kcal/mol [24].
Conversely, if KL4 assumes a structure with a lower helical pitch, its
hydrophobic moment is increased by 3–4 kcal/mol and its insertion in
a TM orientation is much less favorable (Fig. 1B or C). Our structural
studies of KL4 interacting with POPC/POPG and DPPC/POPG vesicles
suggest that this latter scenario is correct for the peptide under fully
hydrated conditions.
An alternative means to assay the orientation of KL4 in lipid
bilayers as well as its partitioning behavior is to examine the
dynamics of the leucine side chains at various positions in the
peptide. The nonperturbing nature of incorporating 2H into 5-d3-L-
leucine and the increased sensitivity for 2H solid-state NMR due to
the three-fold rotation of the methyl group make this a particularly
attractive probe for assaying dynamics. Previously, deuterated
leucine has been utilized for examining dynamics and oligomeriza-
tion of transmembrane sequences [30,35,36]. However, to our
knowledge, it has not been used to examine the partitioning of
amphipathic helices into lipid bilayers. The frequency and symmetry
of the leucines in the KL4 sequence make the identiﬁcation of a
Fig. 6.Model of the possible structures and orientations of KL4 in the lipid bilayer: (A) a canonical α-helix in a transmembrane orientation; (B) an α-helix in the plane of the bilayer;
(C) the helix from Fig. 1C in a transmembrane orientation; and (D) the helix from Fig. 1C lying in the plane of the bilayer. The deuterated leucine methyl groups used in this study are
color-coded with respect to their relative dynamics in POPC/POPG at 40 °C with Leu3 (red)NLeu 12 (orange)NLeu10≈Leu19 (yellow).
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assay the orientation of the peptide, we chose two sites at the N- and
C-termini (Leu3 and Leu19) as well as two sites which would be
located near the center of the bilayer in a TM orientation (Leu10 and
Leu12). Under all experimental conditions, the relative dynamics of
these positions suggests that a TM orientation is unlikely, particularly
since the dynamics of Leu10 and Leu12 differs signiﬁcantly. While
packing of peptide helices in aggregates could lead to differences
between these two positions, we do not see a loss of motion about
the Cβ\Cγ and/or Cα\Cβ bonds at any of the observed positions as
would be expected for helix–helix packing interactions. Additionally,
the dynamics observed at the various temperatures was easily
reproduced regardless of the order in which spectra were collected
consistent with all changes in dynamics being reversible and the
samples being fully equilibrated.
Leucine side chains are particularly sensitive to packing of side
chains at helix interfaces. While we did not assay all possible helix
interfaces in this study, the labels chosen lie at expected interfaces if
the peptide were to oligomerize in the plane of the membrane. Above
the gel→liquid crystalline phase transition temperature of the lipids,
all samples exhibited leucine side chain dynamics about the Cβ\Cγ
and/or Cα\Cβ bonds. This is in contrast to what has been observed for
leucines found at helix interfaces [30]. In our studies we have found
KL4 to form consistent secondary structure in phospholipids mixtures
up to P/L ratios of 1:30. At 1:20, CD and FTIR spectra indicate theformation of β-sheet type structures consistent with aggregation of
the peptide (K. Seu and S Decatur, personal communication).
As can be seen in Fig. 1, differences in helix pitch lead to differences
in the expected correlations between the labeled positions for the
peptide lying in the plane of the lipid bilayer. For DPPC/POPG and
POPC/POPG lipid mixtures near physiologic temperature, the corre-
lation in side chain dynamics among the four observed positions
is consistent with a peptide having a high hydrophobic moment
(Fig. 1C), which agrees well with our structural measurements carried
out on KL4 in DPPC/POPG lipid vesicles (A.K. Mehta and J.R. Long,
submitted for publication). Near room temperature, the dynamics
observed for KL4 in POPC/POPG lipid vesicles correlate with the
helical structure previously determined under the same conditions
[22]. Based on these observations, only one of the four models in Fig. 5
is consistent with our data near physiologic temperature, as indicated.
In this study, the dynamics observed for the KL4 leucine side chains
in DPPC/POPG-containing samples is signiﬁcantly attenuated relative
to the POPC/POPG-containing samples. This is consistent with
previous observations that addition of peptide lowers the acyl chain
order parameters in POPC/POPG lipid bilayers but increases the acyl
chain order parameters in DPPC/POPG lipid bilayers [29]. This
variation in partitioning depth is likely due to the unusual periodicity
of the hydrophilic residues which confer temperature-dependent
helical plasticity on partitioning of the peptide into lipid bilayers with
varying levels of saturation.
222 J.R. Long et al. / Biochimica et Biophysica Acta 1798 (2010) 216–222Lipid polymorphisms that change the geometry and arrangement of
lipid assemblies may be critical for lipid adsorption at the alveolar air–
ﬂuid interface [39]. The enrichment of DPPC at the air–water interface
has been postulated as one of themajor roles of SP-B. The KL4 peptide's
structural plasticity and variable penetration depth can affect the
stability and composition of lung surfactant lipid structures by causing
negative curvature strain as we have demonstrated in POPE/POPG
phospholipid mixtures. These changes in curvature strain provide a
mechanism for lipid trafﬁcking from lamellar bodies and tubular
myelin to the air–water interface in amanner thatmay select for DPPC.
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